Table 1 Clinical characteristics between non-rebleeding and rebleeding groups
Variables | All subjects (N = 360) | Non-rebleeding (N = 309) | Rebleeding (N = 51) | p value |
|---|---|---|---|---|
Sex (n [%]) | 0.463 | |||
Male | 302 (83.9) | 261 (84.5) | 41 (80.4) | |
Female | 58 (16.1) | 48 (15.5) | 10 (19.6) | |
Age(years), [median (IQR)] | 50 (37–61) | 50 (37–60.5) | 55 (36–65) | 0.226 |
Age ≥ 60 years (n [%]) | 105 (29.2) | 86 (27.8) | 19 (37.3) | 0.172 |
Alcoholics (n [%]) | 62 (17.2) | 55 (17.8) | 7 (13.7) | 0.475 |
Smokers (n [%]) | 102 (28.3) | 87 (28.2) | 15 (29.4) | 0.854 |
Medication history (n[%]) | ||||
Use of anti-platelets | 18 (5.0) | 14 (4.5) | 2 (3.9) | 0.845 |
Use of NSAIDS | 11 (3.1) | 9 (2.9) | 2 (3.9) | 0.698 |
Use of anticoagulants | 6 (1.7) | 6 (1.9) | 0 (0) | 1 |
PUB history (n [%]) | 96 (26.7) | 81 (26.2) | 15 (29.4) | 0.632 |
Comorbidity (n [%]) | ||||
Strokes | 10 (2.8) | 6 (1.9) | 4 (7.8) | 0.018 |
Coronary artery disease | 7 (1.9) | 7 (2.3) | 0 (0) | 0.278 |
Chronic renal disease | 24 (6.7) | 20 (6.5) | 4 (7.8) | 0.716 |
Liver cirrhosis | 11 (3.1) | 7 (2.3) | 4 (7.8) | 0.032 |
Hypertension | 89 (24.7) | 75 (24.3) | 14 (27.5) | 0.626 |
Diabetes mellitus | 28 (7.8) | 25 [8.1] | 3 (5.9) | 0.585 |
Systolic blood pressure(mm Hg), [median(IQR)] | 116 (105–128) | 117 (106–128) | 115 (103–130) | 0.824 |
Systolic blood pressure < 90 mmHg (n [%]) | 20 (5.6) | 18 (5.8) | 2 (3.9) | 0.582 |
Heart rate (beats/min), [median (IQR)] | 85 (75–96) | 84 (75–94) | 92 (74–106) | 0.018 |
Heart rate > 100 beats/min (n [%]) | 60 (16.7) | 39 (12.6) | 21 (41.2) | < 0.001 |
Shock (n [%]) | 43 (11.9) | 13 (4.2) | 30 (58.8) | < 0.001 |
Glasgow Blatchford Score, median (IQR) | 9 (7–11) | 9 (7–11) | 12 (9–14) | < 0.001 |
Rockall Score, median (IQR) | 4 (3–5) | 4 (3–4.5) | 5 (4–6) | < 0.001 |
AIMS65 Score, median (IQR) | 0 (0–1) | 0 (0–1) | 1 (1–2) | < 0.001 |